Literature DB >> 11684012

Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling.

W Lu1, D Gong, D Bar-Sagi, P A Cole.   

Abstract

The regulation of protein tyrosine phosphatase (PTPase) SHP-2 is proposed to involve tyrosine phosphorylation on two tail tyrosine residues. Using "expressed protein ligation", nonhydrolyzable phosphotyrosine analogs were introduced at known phosphorylation sites in SHP-2. Biochemical analysis suggests that a phosphonate at Tyr542 interacts intramolecularly with the N-terminal SH2 domain to relieve basal inhibition of the PTPase, whereas a phosphonate at Tyr-580 stimulates the PTPase activity by interaction with the C-terminal SH2 domain. Microinjection experiments indicate that a single phosphorylation of Tyr-542 of SHP-2 is sufficient to activate the MAP kinase pathway in living cells. These studies support a novel mechanism explaining how tyrosine phosphorylation of a PTPase is important in signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684012     DOI: 10.1016/s1097-2765(01)00369-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  89 in total

1.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Structure-based kinetic models of modular signaling protein function: focus on Shp2.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

3.  The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells.

Authors:  Yi Zhan; George J Counelis; Donald M O'Rourke
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

4.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

5.  Shp2 acts downstream of SDF-1alpha/CXCR4 in guiding granule cell migration during cerebellar development.

Authors:  Kazuki Hagihara; Eric E Zhang; Yue-Hai Ke; Guofa Liu; Jan-Jan Liu; Yi Rao; Gen-Sheng Feng
Journal:  Dev Biol       Date:  2009-07-25       Impact factor: 3.582

6.  S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke.

Authors:  Zhong-Qing Shi; Carmen R Sunico; Scott R McKercher; Jiankun Cui; Gen-Sheng Feng; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

7.  F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.

Authors:  S P Gorantla; K Zirlik; A Reiter; C Yu; A L Illert; N Von Bubnoff; J Duyster
Journal:  Leukemia       Date:  2015-03-12       Impact factor: 11.528

Review 8.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 9.  Proinflammatory stem cell signaling in cardiac ischemia.

Authors:  Jeremy L Herrmann; Troy A Markel; Aaron M Abarbanell; Brent R Weil; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

10.  SHP-2 is a novel target of Abl kinases during cell proliferation.

Authors:  Sayan Mitra; Carol Beach; Gen-Sheng Feng; Rina Plattner
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.